Actively Recruiting
Early Rheumatoid Arthritis Lung Disease Study
Led by University of Nebraska · Updated on 2025-08-08
100
Participants Needed
1
Research Sites
621 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Extra-articular (outside of joints) disease occurs in approximately 50% of rheumatoid arthritis (RA) patients, with the lung being a common site of involvement. The goals of this study are to investigate and characterize lung disease and its prevalence in early RA participants. This will be done through pulmonary function and high resolution chest computed tomography (CT), questionnaires, and serum studies. Another goal is to find novel biomarkers, such anti-malondialdehyde-acetaldehyde (MAA) antibodies, as predictors of lung disease in RA participants.
CONDITIONS
Official Title
Early Rheumatoid Arthritis Lung Disease Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 19 to 90 years of age
- Able to give informed consent
- Diagnosis of rheumatoid arthritis by a rheumatologist using 2010 American College of Rheumatology criteria within the past 2 years
You will not qualify if you...
- Inflammatory arthritis that does not meet 2010 American College of Rheumatology criteria for rheumatoid arthritis
- Pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198
Actively Recruiting
Research Team
A
Aimee B Schreiner, MS
CONTACT
B
Bridget Kramer, RN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here